Title |
The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures
|
---|---|
Published in |
Frontiers in Pharmacology, January 2021
|
DOI | 10.3389/fphar.2020.591134 |
Pubmed ID | |
Authors |
Evelien Moorkens, Brian Godman, Isabelle Huys, Iris Hoxha, Admir Malaj, Simon Keuerleber, Silvia Stockinger, Sarah Mörtenhuber, Maria Dimitrova, Konstantin Tachkov, Luka Vončina, Vera Vlahović Palčevski, Gnosia Achniotou, Juraj Slabý, Leona Popelková, Kateřina Kohoutová, Dorthe Bartels, Ott Laius, Jaana E. Martikainen, Gisbert W. Selke, Vasileios Kourafalos, Einar Magnússon, Rannveig Einarsdóttir, Roisín Adams, Roberta Joppi, Eleonora Allocati, Arianit Jakupi, Anita Viksna, Ieva Greičiūtė-Kuprijanov, Patricia Vella Bonanno, Vincent Suttorp, Øyvind Melien, Robert Plisko, Ileana Mardare, Dmitry Meshkov, Tanja Novakovic, Jurij Fürst, Corinne Zara, Vanda Marković-Peković, Nataša Grubiša, Gustaf Befrits, Robert Puckett, Arnold G. Vulto |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 13% |
Finland | 1 | 13% |
Australia | 1 | 13% |
Italy | 1 | 13% |
United Kingdom | 1 | 13% |
Poland | 1 | 13% |
Switzerland | 1 | 13% |
Unknown | 1 | 13% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 7 | 88% |
Scientists | 1 | 13% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 49 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 6 | 12% |
Student > Master | 5 | 10% |
Other | 4 | 8% |
Student > Ph. D. Student | 4 | 8% |
Lecturer | 2 | 4% |
Other | 8 | 16% |
Unknown | 20 | 41% |
Readers by discipline | Count | As % |
---|---|---|
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 8% |
Medicine and Dentistry | 4 | 8% |
Business, Management and Accounting | 4 | 8% |
Unspecified | 2 | 4% |
Biochemistry, Genetics and Molecular Biology | 2 | 4% |
Other | 9 | 18% |
Unknown | 24 | 49% |